Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Methods of treating multiple myeloma with bispecific anti-BCMA x anti-CD3 antibodies

Methods of treating multiple myeloma with bispecific anti-BCMA x anti-CD3 antibodies

US Patent 11919965 · Granted Mar 5, 2024

Estimated economic value: $186,270,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Intralesional administration of PD-1 inhibitors for treating skin cancer2025
Combination therapy to treat brain cancer2025
Methods for dehydrogenating hydrocarbons2025
Hydrogen-selective oxygen carrier materials and methods of use2024
Devices, systems, and methods for assessing facility compliance with infectious 2024
Combination of anti-PD-1 antibodies and bispecific anti-CD20/anti-CD3 antibodies2024
Anti-PD-1 antibodies for treatment of lung cancer2024
Methods of producing hydrogen-selective oxygen carrier materials2023
Methods for dehydrogenating hydrocarbons2023
Dosing strategy that mitigates cytokine release syndrome for therapeutic antibod2023
Dosing strategy that mitigates cytokine release syndrome for therapeutic antibod2023
Methods of treating skin cancer by administering a PD-1 inhibitor2022